A discussion paper about the Value of Treatment for Brain Disorders was released on 28 February 2017. The Value of Treatment for Brain Disorders (VoT) is a 2-year research project undertaken by EBC with the overall goal of assessing the treatment gaps and the cost of non-(or inadequate) treatments, and promoting a holistic healthcare approach (versus fragmentation and results in silo).
A MULTIPLE GOAL : Bridging the early diagnosis and treatment gaps:
– Target unmet needs towards achieving high value for patients
– Reflect on new research developments
– Conduct cost-effectiveness analysis in health care (comparing costs and values of defined interventions), and assess benefits of coordinated care in the prevention and treatment of brain disorders.
The discussion paper came from a synthesis of previous work: the 18 January 2017 plenary meeting which involved the working groups for each specific disease; preliminary results from case study presentations; experts’ roundtables; and the EBC Board Meetings of 8-9 February 2017.
EBC Discussion Paper 2 as a synthesis focused on:
– Addressing the burden of diseases and issues in the current healthcare, the health services delivery & care pathways design
– Proposing evidence-based and cost-effective solutions to achieve high value for patients.
As results of a literature review, this synthesis report builds on:
– Case studies key preliminary results analysis and interpretation
– Consultations with experts
The European Brain Council would like to thank its Academic Partners, the Working Groups Experts, the External Experts, and the Patients Associations’ Representatives for their constructive insights. The list of participants to the Value of Treatment Meeting of 18 January 2017 is in the Annex.
To read the full discussion paper click here.
